中山大学中山眼科中心（集医教研防一体，历年全国眼科第一）中心主任（院长），中山大学中山医学院遗传学与生物医学信息学系主任，医学人工智能与大数据学科带头人，教授、主任医师、研究员，眼科学和生物医学工程双学科博导。国家“万人计划”科技创新领军人才，国家卫健委突出贡献中青年专家，中国青年五四奖章获得者，全国青联常委，国家重点研发计划项目首席科学家（优秀结项），广东省医学领军人才，并兼任亚非眼科学会（Afro-Asian Council of Ophthalmology）亚洲办公室主任，国家药品监督管理局人工智能医疗器械评审专家，广东省医学会医学人工智能分会首届主任委员，中国人工智能学会智慧医疗专委会副主任委员，广东省青联副主席，广东省青科协常务副会长兼秘书长，《Journal of Medical Artificial Intelligence》主编，《Annals of Eye Science》和《眼科学报》执行主编，《British Journal of Ophthalmology》编委，《中华智慧医学（英文）》创刊编委，主持国家自然基金重大研究计划等项目10余项，以第一及通讯作者发表SCI收录文章100余篇，涵盖Nature、Science、The Lancet、BMJ等国际顶级期刊，主编专著4部，参与编写专著6部，主持研发的多项智能医疗设备和软件系统应用于临床，并申请和获得30余项国内外专利和软件著作权，牵头编制首批湾区标准2项（医学人工智能领域仅此两项），获2021年吴文俊人工智能科技进步一等奖、首届钟南山青年科技创新奖等。
对各种常见眼病的防治具有多年临床经验，尤其擅长各种白内障的手术和先天性白内障等儿童眼病的防治，并创立了眼科人工智能算法和临床应用体系：1）算法创新：提出医学影像人工智能研发的“乐高计划”，首次采用迁移学习视觉分解Visionome算法，将数据效能提升百倍以上，（Nature Biomedical Engineering 2020）；研发“数字面罩”算法，解决患者颜面部疾病诊疗与隐私保护的数据需求矛盾难题（Nature Medicine 2022）。2）智能诊疗：构建全球首个人工智能白内障诊疗云平台（Nature Biomedical Engineering 2017，封面）和近视发展智能预测系统（PLoS Medicine 2018）；研发婴幼儿视功能智能评估系统（Nature Biomedical Engineering 2019，封面），解决了语言前婴幼儿视功能评估的国际难题；创新以眼睛为全身器官系统的健康监测窗口新技术（Lancet Digital Health 2021）。3）落地应用：开启了全球首个眼科人工智能门诊，被IEEE Spectrum评选为“影响全球医学界的11大AI事件”；牵头完成国际首个人工智能多中心随机对照研究（Lancet Discovery Science 2019，封面），被国家卫健委评为“2019年中国十大医学科技新闻”；完成了全球首个眼科多病种人工智能真实世界研究（Lancet Digital Health 2021），被中国医师协会评为“2021年中国眼科十大进展”；创建全球首个数字面罩（Digital Mask），使得智能诊断技术做到“识病不识人”，保护了患者的敏感信息（Nature Medicine 2022）；创新智能“三级诊疗”模式，在全国及“一带一路”沿线35家机构应用，完成眼病筛查超过5千万人次。
Prof. Haotian Lin is the President, Professor, Primary Investigator, PhD mentor of Zhongshan Ophthalmic Center, Sun Yat-Sen University (integrating medicine, teaching, research and prevention together as well as ranked as the No.1 in ophthalmology consecutively for 12 years), and the Director of Department of Genetics and biological informatics, Zhongshan School of Medicine, Sun Yat-sen University. He is the PhD mentor of Center for Precision Medicine and School of Biomedical Engineering, Sun Yat-Sen University.
He has been the member of the American Academy of Ophthalmology (AAO) since 2012. He is currently the Director of Asia Office of Afro-Asian Council of Ophthalmology (AACO-AO), the Deputy Chairman of Intelligent Medical Special Committee of Chinese Association for Artificial Intelligence (CAAI), the Executive Vice President and Secretary of Guangdong Association of Young scientists and the member of Ophthalmic Division of Chinese Medical Association. Prof. Lin was awarded as the “the 24th China Youth May Fourth Medal”, the winner of “the 1st Zhong Nanshan Youth Science and Technology Innovation Award” and “2021 Wu Wenjun Science and Technology Award for Artificial Intelligence”, picked as the “National Youth and Middle-aged Technological Innovation Leaders”.
He is the Chief Scientist of the National Key R&D Program of China, working on the transformation and application of medical big data in diagnosis and artificial intelligence. He led over 10 projects like Major Research Project of National Natural Science Foundation of China. He has edited 2 books as the editor-in-chief, co-written 6 monographs and published more than 100 SCI papers as the first or the corresponding author, including Nature, Science, Lancet, BMJ, Nature Medicine, Nature Biomedical Engineering, PLoS Med, Lancet Discovery Science, etc. He also developed a number of medical equipment and software that successfully applied to clinic. He owned more than 10 patents from China and the US with exceeding additional 20 patents filed.
